Fragmentation of preventive healthcare services across diverse care settings poses significant challenges to achieving optimal patient outcomes, with evidence increasingly highlighting its adverse effects on screening continuity, care quality, and long-term health. This review synthesizes current research, focusing on the magnitude, mechanisms, and clinical implications of preventive service fragmentation, while exploring strategies for integrated screening and guideline-aligned management across healthcare interfaces.
As healthcare delivery becomes progressively complex, the fragmentation of preventive services defined as the disjointed provision of screening and preventive interventions across multiple care settings has emerged as a pressing concern for clinicians and health systems. The seamless delivery of evidence-based preventive screenings is foundational to public health, yet patients frequently traverse primary care, specialty clinics, urgent care centers, and inpatient settings with variable access to consistent screening protocols. This article reviews the epidemiology, underlying mechanisms, and clinical consequences of service fragmentation, and evaluates evolving strategies to enhance coordination and continuity in preventive care.
Multiple cohort and cross-sectional studies underscore the prevalence and burden of fragmented preventive services. For example, a recent analysis of U.S. Medicare beneficiaries revealed that over 45% of older adults received screening tests from more than one healthcare setting within a two-year span, with notable gaps in cancer, cardiovascular, and infectious disease screening adherence. Fragmentation is associated with increased rates of missed, duplicate, or delayed screenings, particularly among patients with multiple chronic conditions or those transitioning between care environments. The burden is amplified in socioeconomically disadvantaged populations, exacerbating health disparities and undermining population health goals.
The pathophysiology of preventive service fragmentation is multifactorial, rooted in systemic, organizational, and information-related factors. Disconnected electronic health records (EHRs), lack of standardized screening protocols across sites, and poor inter-provider communication contribute to breakdowns in care continuity. From a mechanistic standpoint, the absence of centralized patient data repositories fosters redundant care or omission of critical screenings, while care transitions such as hospital discharge to primary care often lack structured processes for preventive care handoffs. These deficiencies increase the risk of preventable morbidity and impede early disease detection.
Key risk factors for preventive service fragmentation include poly-provider care (patients engaging with multiple specialists and primary care providers), high healthcare utilization, frequent care transitions, and limited health system integration. Additional contributors are patient-level factors such as low health literacy and social instability and system-level issues like siloed EHR systems and inconsistent insurance coverage. Vulnerable groups, including the elderly, medically complex, and those residing in rural or underserved areas, are disproportionately affected.
Clinically, fragmentation often manifests as missed opportunities for early disease detection, duplicated screening tests, inconsistent follow-up, and suboptimal adherence to preventive guidelines. Patients may experience confusion regarding recommended screenings, conflicting advice from different providers, or delays in receiving results and subsequent care. These inconsistencies can erode patient trust and satisfaction, while increasing the risk of late-stage disease presentations and avoidable complications.
Identification of preventive service fragmentation relies on both quantitative and qualitative approaches. EHR audits, claims data analysis, and patient surveys are commonly utilized to detect gaps and redundancies in screening delivery. Integrated health information exchanges (HIEs) and care coordination metrics, such as the Continuity of Care Index, have been developed to quantify fragmentation. Qualitative assessment through provider interviews and workflow analysis further elucidates system-level barriers.
Addressing fragmentation requires multifaceted strategies targeting care coordination, information sharing, and patient engagement. Core interventions include implementation of interoperable EHRs, standardized screening checklists, and cross-setting communication protocols. Care navigators and population health management tools can facilitate tracking and completion of preventive screenings. Additionally, patient-centered medical homes (PCMHs) and accountable care organizations (ACOs) are structured to promote integrated care delivery and enhance screening adherence. Clinicians should prioritize clear documentation, proactive reminders, and close collaboration across care teams.
Recent advances center on digital health solutions and system redesign. The use of artificial intelligence (AI)-driven risk stratification tools, patient portals, and mobile health applications has demonstrated promise in identifying screening gaps and prompting timely interventions. Interoperability standards such as FHIR (Fast Healthcare Interoperability Resources) are facilitating real-time data exchange across care settings. Pilot programs integrating community health workers and telehealth for rural or mobility-limited populations have improved screening uptake and reduced fragmentation. Ongoing research is evaluating predictive analytics to tailor screening reminders and optimize resource allocation.
Major guidelines from organizations such as the U.S. Preventive Services Task Force (USPSTF), the American Cancer Society, and the Centers for Disease Control and Prevention (CDC) emphasize the necessity of coordinated, patient-centered preventive screening. Recommendations advocate for integrated care models, routine assessment of screening status at every point of contact, and comprehensive documentation accessible to all involved providers. Adherence to evidence-based intervals and avoidance of unnecessary duplication are key tenets. Health systems are encouraged to invest in EHR interoperability, care transitions programs, and staff training to mitigate fragmentation risks.
Fragmentation of preventive services across care settings remains a critical challenge to achieving high-quality, equitable healthcare. Its impact extends beyond missed screenings to encompass broader issues of patient safety, satisfaction, and health system efficiency. Robust integration of information systems, collaborative care models, and patient engagement initiatives are essential to minimize fragmentation and optimize preventive care delivery. Continued research and policy efforts should focus on scalable solutions that bridge gaps across diverse healthcare environments, ensuring that every patient receives timely, guideline-concordant preventive care.
1.
"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.
2.
Recently released national data on drug use and abuse among Americans.
3.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
4.
Ketamine plus psychotherapy for "excellent" PTSD
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Personalized Tumor Ecological Landscapes in Oncology
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
Preserving Social Identity During Cancer Survivorship
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Regenerative Models of Tumor Microenvironments: Clinical Relevance and Emerging Insights
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
From Guidelines to Practice: Hematology
5.
Breast Cancer Awareness and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation